New Technologies Revolutionize Algerian Medical Biology
New technologies are transforming medical biology laboratories in Algeria, leading to more efficient data analysis and diagnostic processes. This modernization includes plans for electronic medical records and connected hospitals, aligning the national health system with global innovations.

Algeria's medical biology laboratories are undergoing a significant transformation, driven by the integration of new technologies. These advancements are enabling more effective analysis of biological data, optimizing diagnostic processes, and enhancing the incorporation of results into patient care pathways. The health sector in Algeria is embarking on a strategic shift, aiming for a decisive stage by 2027 with the widespread implementation of electronic medical records (EMR) and the adoption of a national identification number to standardize patient follow-up, as highlighted by Minister of Health, Professor Mohamed Seddik Aït Messaoudène.
This evolution within the health system is aligning with major global changes, including the rise of artificial intelligence, connected hospitals, and diagnostic innovation, which are shaping the future of medicine in the country. The structural transformation of Algeria's health sector was a central theme at the "Algeria Mindray Lab Forum 2026" held in Algiers, an event focused on "Shaping the Future of Laboratory Medicine." This high-level scientific and technological gathering brought together Algerian and international experts, health professionals, and medical diagnostic stakeholders with a shared objective: to support the technological modernization of the Algerian health system and facilitate its integration with global medical innovations.
The impact of these innovations is particularly evident in areas such as hematology, where artificial intelligence is creating substantial opportunities through automated cellular morphology analysis. This capability simplifies the identification of abnormal cells and indicative signs of malignant hemopathies, providing crucial support to biologists' expertise. Beyond the laboratory, the concept of connected hospitals represents a further step in modernizing healthcare facilities, fostering a smarter, more efficient, and patient-centered organizational structure through the interconnection of medical equipment, integrated information systems, and secure data circulation.
The advancements are supported by strategic partnerships, such as the collaboration between the Sadid Diagnopharm group and international medical technology leader Mindray. Mindray contributes to a more integrated medical approach by leveraging its ecosystem of digital solutions, automation, and artificial intelligence to reinforce human expertise and aid medical decision-making. Sadid Diagnopharm views these initiatives as part of a broader vision that extends beyond mere equipment provision, aiming to promote technology transfer, cultivate national competencies, and elevate Algerian laboratories and hospitals to international standards.



